Bloomage BioTechnology Corporation Limited (SHA:688363)
China · Delayed Price · Currency is CNY 36.33
-1.97 (-5.14%)
Jul 24, 2026, 3:00 PM CST
SHA:688363 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,951 | 4,199 | 5,371 | 6,076 | 6,359 | 4,948 |
Revenue Growth | -22.36% | -21.82% | -11.61% | -4.45% | 28.53% | 87.93% |
Gross Profit Gross Profit Growth | 2,632 | 2,847 | 3,889 | 4,417 | 4,877 | 3,829 |
Operating Income Operating Income Growth | 193.23 | 235.23 | 232.36 | 570.18 | 961.48 | 746.46 |
Net Income Net Income Growth | 254.82 | 292.06 | 174.27 | 592.56 | 970.92 | 782.33 |
Earnings Per Share EPS Growth | 0.54 | 0.61 | 0.36 | 1.23 | 2.01 | 1.62 |
EPS Growth | 698.64% | 69.44% | -70.73% | -38.81% | 24.07% | 20.00% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Hong Kong Hong Kong Growth | 60.21 | 48.9 | 54.52 | 35.3 | 27.96 |
Mainland China Mainland China Growth | 5,258 | 6,646 | 7,555 | 8,565 | 6,465 |
Offset Offset Growth | -1,522 | -1,690 | -1,955 | -2,603 | -2,125 |
Other Countries or Regions Other Countries or Regions Growth | 402.77 | 366.16 | 420.91 | 361.49 | 579.43 |
Total Total Growth | 4,199 | 5,371 | 6,075 | 6,359 | 4,947 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,065 | 1,028 | 749.29 | 1,309 | 2,137 | 2,654 |
Total Debt Total Debt Growth | 394.32 | 341.38 | 359.69 | 208.1 | 389.79 | 300.01 |
Net Cash (Debt) Net Cash Growth | 670.31 | 686.9 | 389.6 | 1,101 | 1,747 | 2,354 |
Net Cash Growth | 147.76% | 76.31% | -64.60% | -37.00% | -25.77% | 12.67% |
Net Cash Per Share Net Cash Per Share Growth | 1.42 | 1.43 | 0.80 | 2.28 | 3.62 | 4.87 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 781.39 | 627.45 | 564.51 | 699.65 | 635.19 | 1,276 |
Capital Expenditures CapEx Growth | -331.44 | -325.68 | -721.39 | -1,030 | -696.41 | -784.21 |
Free Cash Flow Free Cash Flow Growth | 449.95 | 301.77 | -156.88 | -330.68 | -61.22 | 491.85 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.62% | 67.80% | 72.41% | 72.69% | 76.69% | 77.40% |
Operating Margin | 4.89% | 5.60% | 4.33% | 9.38% | 15.12% | 15.09% |
Pretax Margin | 6.80% | 7.95% | 3.97% | 11.55% | 17.87% | 17.99% |
Profit Margin | 6.45% | 6.96% | 3.25% | 9.75% | 15.27% | 15.81% |
FCF Margin | 11.39% | 7.19% | -2.92% | -5.44% | -0.96% | 9.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.190 | 0.190 | 0.110 | 0.380 | 0.610 | 0.490 |
Dividend Per Share Growth | 72.73% | 72.73% | -71.05% | -37.70% | 24.49% | 19.51% |
Dividend Yield | 0.52% | 0.44% | 0.22% | 0.57% | 0.46% | 0.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 67.43 | 71.54 | 140.10 | 54.41 | 67.03 | 95.28 |
Forward PE | 42.48 | 38.61 | 34.88 | 29.56 | 51.50 | 90.88 |
P/FCF Ratio | 38.62 | 69.24 | - | - | - | 151.56 |
PS Ratio | 4.40 | 4.98 | 4.55 | 5.31 | 10.23 | 15.07 |